Tuesday, November 17th, 2020 - The Insight Partners

Atrial fibrillation also referred to as AFib or AF is a medical condition that causes irregular heartbeat (arrhythmia) and which can further lead to blood clots, stroke, heart failure and other heart-related complications. The global atrial fibrillation market is driven by factors such as include increasing prevalence of atrial fibrillation and rising awareness regarding atrial fibrillation are expected to boost the market growth over the years. However, high cost of atrial fibrillation devices and procedures is likely to have negative impact on the growth of the market in the coming years.

Moreover, due COVID-19 pandemic, there has been growing demand for atrial fibrillation drugs because arrhythmia occurrences have been observed in most of the COVID patients. For instance, according to the cardiology magazine of March 2020  in Unites State, up to 440,000 hospitalized and as many as 36,000 deaths in the U.S. alone and most of the patients developed the risk of incident atrial fibrillation (H.R., 0.94; p=0.009). Therefore, so many uses of antiarrhythmic drugs and different beta-blockers in North American region is likely to increase the demand for atrial fibrillation drugs for treatment purpose.

Download PDF Report Sample with statistical info @ https://www.theinsightpartners.com/sample/TIPRE00003531/

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

Note – The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries. This report on ‘Atrial fibrillation Market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2027, factoring the impact of Covid -19 Situation.

Leading companies operating in the atrial fibrillation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc, Biosense Webster, Inc., BOEHRINGER INGELHEIM GMBH, CardioFocus, Abbott, Sanofi, Biotronik, Inc., and Bristol-Myers Squibb Company among others.

The global Atrial Fibrillation Market, based on the treatment type, is segmented into non-pharmacological, and pharmacological. In 2019, the non-pharmacological accounted for the largest market share in the global atrial fibrillation market by treatment type owing to common use of surgical devices for the treatment of cardiac arrhythmias. Moreover, medications to treat atrial fibrillation are not always successful and hence non-pharmacological techniques are widely adopted. Thus, owing to these benefits and their wide acceptance of non-pharmacological techniques the non-pharmacological held the largest share in the market. The end user segment is segmented into hospitals, ambulatory surgical centers, and cardiac catheterization laboratories

Atrial fibrillation, is the most common type of heart disorder, where the heart beats too fast, too slow, or in an irregular way. The Centers for Disease Control and Prevention (CDC) estimated that between 2.7 million and 6.1 million people are suffering from AFib in the United States. In 2017, around 166,793 death certificates mention AFib and was the main cause death in 26,077 deaths. Every year over 454,000 hospitalizations were due to AFib in the United States and every year about 158,000 deaths are due to atrial fibrillation.

The report segments Global Atrial Fibrillation Market as follows:

Global Atrial Fibrillation Market - By Treatment Type

Non - pharmacological

MAZE Surgery

Catheter Ablation

Electric Cardioversion


Anti-arrhythmic Drugs

Anti-coagulant Drugs

Global Atrial Fibrillation Market - By End User


Ambulatory Surgical Centers,

Cardiac Catheterization Laboratories

Purchase This Report at: https://www.theinsightpartners.com/buy/TIPRE00003531/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

Call: +1-646-491-9876

Email: [email protected]

Contact Profile

The Insight Partners

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Sameer Joshi
P: +1-646-491-9876
W: www.theinsightpartners.com/


Atrial fibrillation market was valued at US$ 6,446.08 million in 2019 and is expected to grow at a CAGR of 14.0% from 2020 to 2027 to reach US$ 18,085.96 million by 2027.




More Formats

View QR Code